Amanote Research
Register
Sign In
Adverse Effect Profile of Topical Ocular Administration of Fingolimod for Treatment of Dry Eye Disease
Basic and Clinical Pharmacology and Toxicology
- United States
doi 10.1111/bcpt.12717
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Toxicology
Pharmacology
Date
January 22, 2017
Authors
Weibao Xiao
Li Sun
Nan Zhang
Wen Ye
Publisher
Wiley
Related search
Topical Administration of Lacritin Is a Novel Therapy for Aqueous-Deficient Dry Eye Disease
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Effect of a New Topical Soft Steroid Hydrocortisone Phosphate 0.335% on Treatment of Dry Eye Disease
Acta Ophthalmologica
Medicine
Ophthalmology
Etiology, Prevalence, and Treatment of Dry Eye Disease
Clinical Ophthalmology
Ophthalmology
Macrophage Phenotype in the Ocular Surface of Experimental Murine Dry Eye Disease
Archivum Immunologiae et Therapiae Experimentalis
Medicine
Allergy
Immunology
Lifitegrast Ophthalmic Solution 5.0% Versus Placebo for Treatment of Dry Eye Disease
Ophthalmology
Ophthalmology
Lacrimal Gland, Ocular Surface, and Dry Eye
Journal of Ophthalmology
Ophthalmology
Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia
Journal of Ocular Pharmacology and Therapeutics
Ophthalmology
Pharmacology
Diagnostic Tools for Dry Eye Disease
European Ophthalmic Review
Dry Eye Management: Targeting the Ocular Surface Microenvironment
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical